Contineum Therapeutics, Inc.
USD15.22
+0.23 (+1.50%)
CEO
Carmine N. Stengone
IPO Date
2024-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.13
Prev. Close
$15.00
Day Low
$14.13
Day High
$15.22
52W Low
$3.72
52W High
$16.33
Market Cap
$0.57B
Volume
0.00M
| 19,000 |
| $14.19 |
| 26 Jun 2026 | Ware Olivia C | director | A-Award | Acquired | 19,000 | $14.19 |
| 26 Jun 2026 | Schimmelpennink Evert B. | director | A-Award | Acquired | 19,000 | $14.19 |
| 26 Jun 2026 | Ignelzi Troy A. | director | A-Award | Acquired | 19,000 | $14.19 |
| 26 Jun 2026 | Brady Todd R. | director | A-Award | Acquired | 19,000 | $14.19 |
| 26 Jun 2026 | Boyce Sarah | director | A-Award | Acquired | 19,000 | $14.19 |
| 1 Jun 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 4,170 | $13.16 |
| 1 May 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 3,870 | $13.06 |
| 1 May 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 300 | $13.84 |